Hilden, Germany, and German, Maryland (ots / PRNewswire) –
QIAseq Targeted NGS panels provide highly sensitive, undistorted and precise findings on NGS-based
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of a comprehensive portfolio of innovative QIAseq NGS panels known. These are based on innovative proprietary technology for “Digital NGS” that allows an unbiased, accurate quantification of DNA, RNA and miRNA molecules using next-generation sequencing (NGS). When Digital NGS a novel Molecular indexing technology is used, which is compatible with all major sequencing platforms and a more accurate quantitation and detection of molecular variants possible.
In combination with modern primer design and proprietary test chemistry QIAseq Targeted panels allow reliable detection of even extremely rare mutations (mutations at low frequency) as well as a highly efficient sequencing of GC-rich regions. In addition, a precise identification and quantification of otherwise often unrecognized genetic variations is ensured by this approach. These features essential, has hardly covered customer needs are addressed.
The QIAseq panels are integrated into highly integrated sample-to-Insight workflows that include cloud-based bioinformatics tools for advanced data analysis and evaluation. They can be used for all common sample types and are available for various present in the market NGS platforms. The test Roadmap for Gene Reader NGS system of QIAGEN also relies on digital NGS, whereby this fully automated NGS workflow is extended by a further unique performance advantage
The full press release can be found here (https:. / /www.qia gen.com/about-us/press-releases/pressreleaseview?ID=%7b2B299613-499B- 4167-8017-D43160DF6018%7d&lang=de-DE)
https://www.qiagen.com/about-us/press-releases/pressreleaseview?ID = {2B299613-499B-4167-8017-D43160DF6018} & amp; lang = en-US
Public Relations:.
Dr Thomas Theuringer
Senior Director Public Relations
+49 2103 29 11826
email: pr@qiagen.com
http://www.twitter.com/qiagen https: // www .facebook.com / QIAGEN
pr.qiagen.com
Investor Relations:
John Gilardi
Vice President Corporate Communications and Investor Relations
+49 2103 29 11711
email: ir@qiagen.com
ir.qiagen.com
OTS: Qiagen NV newsroom: http://www.presseportal.de/nr/76066 newsroom via RSS: http://www.presseportal.de/rss/pm_76066.rss2 ISIN: NL0000240000
No comments:
Post a Comment